Bristol-Myers Squibb revenue and financials

BMY · NYSE · USD

$59.59Change from previous close: +1.33%Absolute change: +$0.78

Close · October 6, 2026

In the fiscal year ended December 2025, Bristol-Myers Squibb reported revenue of $48.19B (−0.22% year over year). Net income was $7.05B, a net margin of 14.6%.

Annual revenue · 2025: $48.19B
  1. $19.43B2016
  2. $20.78B2017
  3. $22.56B2018
  4. $26.15B2019
  5. $42.52B2020
  6. $46.39B2021
  7. $46.16B2022
  8. $45.01B2023
  9. $48.3B2024
  10. $48.19B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
−0.22%
2025 vs 2024
Net margin
14.6%
2024: -18.5%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Operating cash flow3,3931,1041,9746,3113,9171,9544,4395,5912,3262,8344,2524,751
Depreciation and amortization6116111,0241,0509901,0131,8492,6442,5842,4982,4492,472
Capital expenditure-305-347-370-320-361-260-378-324-262-284-330-342
Investing cash flow-1,614-131-1,458-1,702-473-499-196-219-1,319-19,618-1,346-410
Financing cash flow-2,630-1,560-6,029-1,490-1,836-993-1,642-3,852-4,02314,644967-5,160
Dividends paid-1,287-1,283-1,262-1,263-1,262-1,258-1,218-1,216-1,217-1,212-1,160-1,191
Share repurchases———————————-4,000
Debt issued-1303215,3345.058.0368-40595.032615,9534,222-10.0
Debt repaid-1,220-500-10,068-229-643——-2,747-3,126—-2,120—
Effect of exchange rates-10.0-48.05.0-4.012866.0-14777.0-22.0-45.078.0-38.0
Net change in cash-861-635-5,5083,1151,7365282,4541,597-3,038-2,1853,951-857
Free cash flow3,0887571,6045,9913,5561,6944,0615,2672,0642,5503,9224,409
Levered free cash flow2,9642216704,2654,7031,5164,2415,5982,5994,4804,8603,682